CALGARY, March 30 /PRNewswire-FirstCall/ - Stem Cell Therapeutics Corp. ("SCT") is pleased to announce it has accepted an invitation to speak and participate in a panel at BIO 2006, to be held April 9 - 12, in Chicago, Illinois. Dr. Craig Sherburne, Corporate Counsel and Intellectual Property Manager will present on behalf of SCT on April 10, 2006, and participate in the panel discussion of "Stem Cell and Cell Therapy: From Inception to Market Launch".
"The BIO 2006 sessions will feature many industry leaders from among the disciplines of science, finance, business, law, and government policy," said Dr. Joseph Tucker, President and CEO of SCT. "We are proud that Dr. Sherburne and SCT have been invited to participate along with such a distinguished peer group."
The business, science, and regulatory aspects of stem cell research and regenerative medicine will be a focal point at the Biotechnology Industry Organization's BIO 2006 Annual International Convention. Eight panel sessions will cover the issue at BIO 2006, the largest biotech conference in the world.
About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a biotechnology company focused on the development of its technology platform and intellectual property to selectively induce a patient's own stem cells to proliferate in the brain. SCT's core technology, which includes its lead therapeutic product NTx(TM)-265, has been demonstrated to increase the number of innate adult stem cells that grow in place when this therapeutic approach is applied to test animals. SCT plans to develop this fundamental technology further for specific disease treatments such as stroke and potentially Huntington's disease, Alzheimer's disease and other neurodegenerative conditions.
About BIO 2006: BIO 2006 will draw 18,000 life science professionals from around the world to network and learn about the future of the industry through an expansive exhibit hall and a series of thought-provoking, educational programs. Sponsored by the Biotechnology Industry Organization (BIO), the 14th annual international convention will take place April 9-12 at Chicago's McCormick Place Convention Center.
About BIO: BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. The exhibit hall at BIO 2006 will be the largest gathering of biotechnology exhibitors in history, encompassing more than 1,600 companies, organizations and institutions, representing every aspect of the biotechnology industry.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
These securities have not been registered under the United States Securities Act of 1933, as amended, or the securities laws of any state, and may not be offered or sold within the United States or to, or for the account or benefit of U.S. persons unless an applicable exemption from U.S. registration requirements is available.
Except for historical information, this press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting.
Stem Cell Therapeutics Corp.CONTACT: For further information on Stem Cell Therapeutics Corp., visitwww.stemcellthera.com or contact: Dr. Joseph Tucker, Chief ExecutiveOfficer, Stem Cell Therapeutics Corp., Phone : (403) 245-5495,info@stemcellthera.com
